| http://www.w3.org/ns/prov#value | - Since its first successful use in 1968, BMTs have been used to treat patients diagnosed with leukaemia, aplastic anaemia, lymphomas such as Hodgkin's disease, multiple myeloma, immune deficiency disorders and some solid tumours such as breast and ovarian cancer.
|
